Related Experiment Videos
Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment
L La Mantia1, F Riti, C Milanese
1Divisione di Neurologia, Istituto Neurologico C. Besta di Milano, Italy.
Italian Journal of Neurological Sciences
|October 1, 1994
Summary
Evoked potentials correlate with clinical disability in Multiple Sclerosis (MS) patients. These electrophysiological measures may help monitor MS activity and treatment effectiveness during acute bouts.
Area of Science:
- Neuroscience
- Clinical Neurology
- Electrophysiology
Background:
- Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Acute relapses in MS are characterized by neurological deficits and can be treated with corticosteroids.
- Monitoring disease activity and treatment response in MS is crucial for patient management.
Purpose of the Study:
- To evaluate the utility of multimodal sensory evoked potentials (EPs) in assessing disease activity and treatment efficacy in relapsing-remitting MS patients.
- To investigate the correlation between electrophysiological findings and clinical disability scores.
- To explore differences in electrophysiological profiles among patients treated with different corticosteroid regimens.
Main Methods:
- Serial recordings of visual, acoustic, and somatosensory evoked potentials were performed in 19 relapsing-remitting MS patients.
- Patients were enrolled in a clinical trial comparing dexamethasone with high- and low-dose methylprednisolone for acute MS bouts.
- Electrophysiological and clinical evaluations were conducted at baseline and up to 6 months post-treatment, utilizing an Evoked Potentials score.
Main Results:
- A positive correlation was observed between the Evoked Potentials score and clinical disability scores in MS patients.
- Distinct electrophysiological profiles were identified across the three treatment subgroups (dexamethasone, high-dose methylprednisolone, low-dose methylprednisolone).
- Changes in EPs reflected disease activity and potentially treatment effects over the 6-month follow-up period.
Conclusions:
- Multimodal sensory evoked potentials show promise as a tool for monitoring acute Multiple Sclerosis activity.
- EPs may aid in evaluating the therapeutic effects of corticosteroids in MS management.
- Electrophysiological assessments can provide objective insights into disease progression and treatment response in MS.